Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05664477 · ClinicalTrials.gov registry record · Phase 2

PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition

A Phase 2 study of Menopause and Cognitive Change, sponsored by Roberta Brinton.

Active
Registry status
Phase 2
Development phase
100
Enrollment target
2
Study locations

NCT05664477 is a Phase 2 study of Menopause and Cognitive Change that is active but no longer recruiting, run by Roberta Brinton. The registered enrollment target is 100 participants, below the 9,392-participant average among 54 other Menopause trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05664477, a Phase 2 study of Menopause and Cognitive Change, is active but no longer recruiting, sponsored by Roberta Brinton.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
100 participants
Enrollment target
2
Study locations

Study Summary

This is a proof-of-concept phase 2 clinical trial to investigate the safety and effect of the phytoestrogenic supplement PhytoSERM on regional brain metabolism by fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in peri- and postmenopausal women. The investigators hypothesize that there will be a significant difference between the PhytoSERM group and placebo group in glucose brain metabolism.

Conditions Studied

Menopause Cognitive Change Brain Disorder, Metabolic

Interventions

  • DRUG Placebo
  • DIETARY_SUPPLEMENT PhytoSERM

Study Locations (2)

Arizona

  • University of Arizona / Clinical & Translational Sciences Research Center (CATS - Tucson

New York

  • The Alzheimer's Prevention Program / Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-01-10
Est. Completion 2027-01-31
Phase Phase 2

Sponsor

Roberta Brinton

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05664477

The ClinicalTrials.gov registry entry for NCT05664477 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,392-participant average among 54 other Menopause trials with a reported enrollment target (99% lower). The listed sponsor is Roberta Brinton, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Menopause appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05664477 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, New York.

Frequently Asked Questions

What is clinical trial NCT05664477 about?

NCT05664477 is a clinical study titled "PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition". This is a proof-of-concept phase 2 clinical trial to investigate the safety and effect of the phytoestrogenic supplement PhytoSERM on regional brain metabolism by fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in peri- and postmenopausal women. The investigators hypothesiz...

What is the current status of trial NCT05664477?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2024-01-10. Estimated completion is 2027-01-31.

What conditions does trial NCT05664477 study?

This clinical trial studies the following conditions: Menopause, Cognitive Change, Brain Disorder, Metabolic.

What interventions are being tested in trial NCT05664477?

The interventions under investigation include: Placebo (DRUG), PhytoSERM (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05664477?

This trial is sponsored by Roberta Brinton, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05664477 being conducted?

This trial has 2 study locations across Arizona, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Menopause

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Menopause

All registered trials for this condition

Cognitive Change

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.